Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Treasury Shares (2018 - 2025)

Dna X filings provide 8 years of Treasury Shares readings, the most recent being $621658.0 for Q1 2025.

  • On a quarterly basis, Treasury Shares fell 8.33% to $621658.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $621658.0, a 8.33% decrease, with the full-year FY2024 number at $3769.0, down 94.47% from a year prior.
  • Treasury Shares hit $621658.0 in Q1 2025 for Dna X, up from $3769.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $2.7 million in Q1 2021 to a low of $3769.0 in Q4 2024.
  • Median Treasury Shares over the past 5 years was $347108.0 (2021), compared with a mean of $648878.7.
  • Biggest five-year swings in Treasury Shares: surged 1088.25% in 2021 and later plummeted 94.47% in 2024.
  • Dna X's Treasury Shares stood at $347108.0 in 2021, then surged by 148.02% to $860888.0 in 2022, then tumbled by 92.08% to $68185.0 in 2023, then plummeted by 94.47% to $3769.0 in 2024, then surged by 16393.98% to $621658.0 in 2025.
  • The last three reported values for Treasury Shares were $621658.0 (Q1 2025), $3769.0 (Q4 2024), and $51724.0 (Q3 2024) per Business Quant data.